Core Viewpoint - Zentek Ltd. has been granted a 180-day extension by Nasdaq to comply with the minimum bid price requirement of $1.00 for continued listing on the exchange [1]. Group 1 - The extension follows the expiration of the initial 180-day period to regain compliance, which ended on February 23, 2026 [1].

GUELPH, ON / ACCESS Newswire / February 17, 2026 / Zentek Ltd.("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN) and (OTC:ZENYF), further to its letter to shareholders dated January 29, 2026, wishes to further outline its strategy, including the transformation of its operating model, near-term derisking steps for the Albany Graphite Project, and a disciplined approach to capital allocation intended to support sustainable value creation over time, as well as updates on its ongoing discourse with Health Cana ...

Core Insights - Zentek Ltd. has announced a strategic reset aimed at capital discipline, sharper execution, and focusing on a smaller number of core platforms with clear paths to value creation [1][4] Strategic Focus - The company will narrow its focus to three core platforms: Albany Graphite, ZenGUARD, and Triera, each with defined milestones and a 24-month roadmap [2] - Non-core initiatives are being paused or wound down to preserve capital and management focus [2] Cost Management - Actions are underway to reduce the company's cost base, including workforce and facility optimization, tighter controls on corporate spending, and a disciplined approach to capital allocation [3] - Future capital raises will be linked to specific milestones rather than open-ended development programs [3] Leadership Changes - The Chief Science Officer, Colin van der Kuur, has departed, and responsibilities have been redistributed among the existing technical leadership team [3] Commitment to Shareholder Value - The CEO emphasized that the reset is about protecting and rebuilding shareholder value, with confidence in the technical expertise and operating team to execute priorities [4] - The company will align its research and development efforts to support the three core platforms and implement new standards for transparency and reporting [4]

Core Insights - Zentek Ltd. has announced that its subsidiary, Albany Graphite Corp., achieved near theoretical anode performance in independent lithium-ion battery testing using ultrahigh purity Albany graphite [1] Company Summary - Zentek Ltd. operates in the lithium-ion battery sector through its subsidiary, Albany Graphite Corp., focusing on high-performance materials [1] - The achievement of near theoretical anode performance indicates significant advancements in the company's product capabilities, potentially enhancing its competitive position in the battery materials market [1]

Group 1 - Zentek Ltd. has appointed Mohammed (Moe) Jiwan as the new Chief Executive Officer and a director, effective December 1, 2025 [1]

Core Points - Zentek Ltd. has received a notice of reassessment from the Canada Revenue Agency regarding its 2019 financial year related to the Flow-Through Financings [1] - The Flow-Through Financings were completed on December 21, 2018, and December 20, 2019, with aggregate gross proceeds of $4,210,000 [1] Financial Impact - The reassessment pertains to the Canadian exploration expenses renunciations for the years 2018 and 2019 [1]

Core Insights - Zentek Ltd. has developed a novel Graphite Gel-Based Fire-Retardant (GBFR) product aimed at protecting homes from wildfires through rapid gelation and intumescent components [1] Company Overview - Zentek Ltd. is an intellectual property technology development and commercialization company [1] - The company is listed on Nasdaq under the ticker ZTEK and on TSX-V under the ticker ZEN [1] Product Development - The new GBFR product combines rapid gelation with intumescent properties to enhance wildfire protection for residential structures [1]

Core Viewpoint - Zentek Ltd. has successfully closed a non-brokered private placement of units, raising gross proceeds of $2,479,227 through the issuance of 2,338,893 units at a price of $1.06 per unit [1][2]. Group 1: Offering Details - Each unit consists of one common share, one-half of a Series A warrant, and one-half of a Series B warrant [2]. - The Series A warrant allows the holder to purchase one common share at $1.50 until October 22, 2027, with potential acceleration of the expiry date if the share price reaches $2.00 for 10 consecutive trading days [3]. - The Series B warrant allows the holder to purchase one common share at $2.00 until October 22, 2028, with potential acceleration if the share price reaches $3.00 for 10 consecutive trading days [4]. Group 2: Financial Aspects - The company paid finder fees totaling $35,429.33 and issued finder warrants for the purchase of 33,424 units at $1.06 per unit until October 22, 2027 [5]. - Proceeds from the offering will be utilized for general and administrative corporate purposes [6]. Group 3: Company Background - Zentek is an intellectual property development and commercialization company focused on enhancing product safety and efficiency through innovative technologies [11]. - The company’s patented ZenGUARD™ technology improves viral filtration efficiency for surgical masks and HVAC systems, with production facilities located in Guelph, Ontario [12].

Core Points - Zentek Ltd. has announced an increase in its non-brokered private placement to a total of up to $2,500,000, allowing for the issuance of up to 2,358,490 Units at a price of $1.06 per Unit [1] - The proceeds from the Offering will be utilized for working capital and general corporate purposes [1] Summary by Sections Offering Details - Each Unit consists of one Common Share, one-half of a Series A Warrant, and one-half of a Series B Warrant [2] - Series A Warrants allow the purchase of one Common Share at $1.50 for 24 months, with potential acceleration if the share price reaches $2.00 for 10 consecutive trading days [3] - Series B Warrants allow the purchase of one Common Share at $2.00 for 36 months, with potential acceleration if the share price reaches $3.00 for 10 consecutive trading days [4] Regulatory and Compliance - The closing of the Offering is subject to necessary corporate and regulatory approvals, including TSXV approval [5] - All securities issued will be subject to a hold period of four months plus a day from the date of issuance [5] Company Overview - Zentek is an ISO 13485:2016 certified intellectual property technology company focused on the research, development, and commercialization of innovative products [7] - The company's patented technology platform, ZenGUARD™, enhances viral filtration efficiency for surgical masks and HVAC systems [8] - Zentek holds a global exclusive license to an Aptamer-based platform technology developed by McMaster University for diagnostic and therapeutic markets [10]

Core Insights - Zentek Ltd. is an intellectual property technology development and commercialization company that has provided an update regarding its subsidiary Albany Graphite Corp. on activities funded by the Critical Minerals Innovation Fund [1] Group 1 - The update follows a previous release dated September 22, 2025, indicating ongoing developments in the company's initiatives [1]